EVIDENCE LIBRARY
Clonazepam in Stiff-Limb Syndrome: Improvement Followed Several Treatments
A rare movement-disorder case described clinical improvement during combined symptomatic and immune-directed treatment.
A rare movement-disorder case described clinical improvement during combined symptomatic and immune-directed treatment.
The reported course
A man developed progressive lower-limb myoclonus and rigidity. The authors favored stiff-limb syndrome after clinical assessment and exclusion of alternatives. Initial treatment included immunoglobulin, baclofen, and clonazepam; later botulinum toxin was followed by further improvement in stiffness.
The case does not separate the components
The report cannot quantify clonazepam’s independent benefit or establish the best treatment sequence. Diagnostic uncertainty in a rare syndrome and the changing course also matter. A response to a benzodiazepine does not alone confirm the diagnosis, and a negative ancillary test does not settle every competing explanation. The paper supports considering the full phenotype and examination while describing treatment response as a combined observation. It is not a randomized efficacy comparison or evidence that all lower-limb jerking should be treated in the same way.
Source paper
Original analysis of the supplied journal article, identified as PMC6919430.